Thomas M. van Himbergen
- Clinical Biochemistry top 2%
- Surgery
- Endocrinology, Diabetes and Metabolism top 10%
- Plant Science
- Molecular Biology
- Co-authors
- Lambertus J.H. van TitsAnton F. H. StalenhoefHieronymus A.M. VoorbijJacqueline de GraafMark RoestSeiko OtokozawaMasumi AiJ. Verhoef
- Topics
- Paraoxonase enzyme and polymorphisms (10 papers)Cynara cardunculus studies (7 papers)Lipoproteins and Cardiovascular Health (6 papers)
- Journals
- PLoS ONEBiochemical and Biophysical Research CommunicationsArteriosclerosis Thrombosis and Vascular Biology
- Partner nations
- NetherlandsUnited StatesJapan
In The Last Decade
Thomas M. van Himbergen
18 papers receiving 721 citations
Peers
Comparison fields: 5 of 76
- Clinical Biochemistry 249
- Surgery 206
- Endocrinology, Diabetes and Metabolism 123
- Plant Science 122
- Molecular Biology 118
Countries citing papers authored by Thomas M. van Himbergen
This map shows the geographic impact of Thomas M. van Himbergen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. van Himbergen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. van Himbergen more than expected).
Fields of papers citing papers by Thomas M. van Himbergen
This network shows the impact of papers produced by Thomas M. van Himbergen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. van Himbergen. The network helps show where Thomas M. van Himbergen may publish in the future.
Co-authorship network of co-authors of Thomas M. van Himbergen
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. van Himbergen. A scholar is included among the top collaborators of Thomas M. van Himbergen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. van Himbergen. Thomas M. van Himbergen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 163 | |
| 3 | 23 | |
| 4 | 35 | |
| 5 | 81 | |
| 6 | 50 | |
| 7 | 29 | |
| 8 | 12 | |
| 9 | 46 | |
| 10 | 1 | |
| 11 | The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicine. | 46 |
| 12 | 36 | |
| 13 | 14 | |
| 14 | 12 | |
| 15 | 72 | |
| 16 | 77 | |
| 17 | 13 | |
| 18 | Indications for a contribution of paraoxonase type-1 to plasma high density lipoprotein levels in patients with familial hypercholesterolemia | 1 |
About Thomas M. van Himbergen
Thomas M. van Himbergen is a scholar working on Clinical Biochemistry, Pharmacology and Molecular Medicine, having authored 18 papers that have together received 728 indexed citations. Recurring topics across this work include Paraoxonase enzyme and polymorphisms (10 papers), Cynara cardunculus studies (7 papers) and Lipoproteins and Cardiovascular Health (6 papers). The work is most often cited by research in Clinical Biochemistry (249 citations), Molecular Medicine (62 citations) and Endocrinology, Diabetes and Metabolism (123 citations). Thomas M. van Himbergen has collaborated with scholars based in Netherlands, United States and Japan. Frequent co-authors include Lambertus J.H. van Tits, Anton F. H. Stalenhoef, Hieronymus A.M. Voorbij, Jacqueline de Graaf, Mark Roest, Mark Roest, Seiko Otokozawa, Masumi Ai, J. Verhoef and Sylvain Brisse. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.